Study to Evaluate the Effectiveness of a Medical Device Based on Hyaluronic Acid in Wounds
The primary objective of the study is to evaluate the safety and performance of a Class IIB medical device based on linear hyaluronic acid used in the treatment of post-surgical wounds. The outcomes of the study are the improvement of wound healing assessed through the Clinical Healing score (score from 0 to 5), which includes the evaluation of: redness, edema, suppuration, healthy granulation tissue and signs of re-epithelialization; the percentage of patients with completely healed wounds at day 30 post-treatment; the pain perceived by the patient when changing the dressing; the frequency of adverse events.
- EligibilityCriteria: Inclusion Criteria:  adult patients with post-surgical wounds subjects capable of complying with the protocol procedures signing of informed consent  Exclusion Criteria:  Pregnancy or breastfeeding inadequate contraceptive procedures in fertile women chronic concomitant treatment with local antiseptics, use of anti-inflammatory drugs (steroids and non-steroids), analgesics, antineoplastics or immunosuppressants non-therapeutic use of psychoactive substances, drug and/or alcohol abuse immunodeficiencies (including HIV infection) Oncology patients; known allergies, hypersensitivity or intolerance to any of the substances administered in this study any medical or non-medical condition that may significantly reduce the possibility of obtaining reliable data and achieving the objectives of the study Participation in clinical trials with devices or drugs within 3 months prior to the screening visit. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult